Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,207 public trials 1,003 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

NCT02259621

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Johns Hopkins at Bayview Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Memorial Sloan Kettering New York, United States
  • Swedish Cancer Insitute Edmonds, Washington, United States
View Trial Details
Active, Not Recruiting

Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

NCT05103605

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Abbeville, France
  • Research Site Aix-en-Provence, France
  • Research Site Angers, France
  • Research Site Antibes, France
View all 46 locations
View Trial Details
Active, Not Recruiting

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

NCT04823377

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • CH Abbeville Abbeville, France
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU Angers Angers, France
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

NCT03052608

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Florida Cancer Specialists Altamonte Springs, Florida, United States
  • Florida Cancer Specialists Brandon, Florida, United States
  • Florida Cancer Specialists Clearwater, Florida, United States
  • Florida Cancer Specialists Gainesville, Florida, United States
View all 166 locations
View Trial Details
Active, Not Recruiting

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Local Institution - 0221 Des Moines, Iowa, United States
  • Local Institution - 0075 Boston, Massachusetts, United States
  • Local Institution - 0201 Boston, Massachusetts, United States
  • Local Institution - 0210 Mineola, New York, United States
View all 122 locations
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

NCT03319940

Conditions
Bites and Stings, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment

NCT05382052

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital Universitario De A Coruna A Coruña, Spain
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Germans Trias I Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
View all 20 locations
View Trial Details
Active, Not Recruiting

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

NCT05781308

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CH Avignon Avignon, France
  • CH Côte Basque Bayonne, France
View all 44 locations
View Trial Details

Related conditions